Who to Look for and When to Act

Omar Noor, MD, focuses on the patients who might otherwise be easy to miss. The small signals that, taken together, start to shift suspicion toward joint disease. 

It all hinges on asking better questions and asking them consistently. From there, treatment becomes a matter of fit. Oral options don’t replace biologics, and they’re not positioned to outperform other systemic therapies. But they do offer a meaningful option for certain patients, particularly when simplicity, preference, and adherence come into play.